Medicine and Dentistry
Acute Myelogenous Leukemia
100%
Hematopoietic Cell
100%
Cell Transplantation
100%
Myelodysplastic Syndrome
100%
Biological Marker
25%
Multiple Myeloma
25%
Risk Stratification
25%
Acute Graft Versus Host Disease
25%
Hazard Ratio
25%
Donor Selection
25%
Disease Severity
25%
Overall Survival
25%
Blood Donor
25%
Chitinase 3 Like Protein 1
25%
Comorbidity
25%
Diseases
25%
Keyphrases
Myelodysplastic Syndrome
100%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
100%
YKL-40
100%
Graft-versus-host Disease (GvHD)
12%
Risk Stratification
12%
Plasma Concentration
12%
Lymphoma
12%
Inflammatory Biomarkers
12%
Multiple Myeloma
12%
Prognostic Value
12%
Disease Severity
12%
Inflammatory Diseases
12%
Confidence Interval
12%
Pretransplant
12%
Overall Survival
12%
95th Percentile
12%
Age-adjusted
12%
Hematopoietic Cell Transplantation-specific Comorbidity Index
12%
Malignant Disease
12%
Treatment-related Mortality
12%
Donor Selection
12%
Aid Donors
12%
Chitinase-3-like Protein 1 (CHI3L1)
12%
Survival Treatment
12%
Adjusted Hazard Ratio
12%
Pharmacology, Toxicology and Pharmaceutical Science
Myelodysplastic Syndrome
100%
Biological Marker
50%
Acute Graft Versus Host Disease
50%
Overall Survival
50%
Disease Severity
50%
Chitinase 3 Like Protein 1
50%
Multiple Myeloma
50%
Comorbidity
50%
Diseases
50%
Immunology and Microbiology
Cell Transplantation
100%
Hematopoietic Cell
100%
Blood Plasma
75%
Acute Graft Versus Host Disease
25%
Blood Level
25%
Overall Survival
25%
Donor Selection
25%
Multiple Myeloma
25%
Comorbidity
25%